The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Silva, Marcelo José Barbosa ^a   Carneiro, Matheus Batista Heitor ^b   Dos Anjos Pultz, Brunna ^a   Pereira Silva, Danielle ^a   Lopes, Mateus Eustáquio De Moura ^b   Dos Santos, Liliane Martins ^b  

^a Laboratório de Biomarcadores Tumorais e Osteoimunologia Instituto de Ciências Biomédicas Universidade de Uberlândia   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACTINOBACTERIA; ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; CITROBACTER RODENTIUM; COLORECTAL CANCER; CYTOKINE RESPONSE; DENDRITIC CELL; DYSBIOSIS; FATTY LIVER; FECES MICROFLORA; FIRMICUTES; GASTROINTESTINAL DISEASE; GENE LOCUS; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE INFECTION; LACTOBACILLUS; MACROPHAGE; NONHUMAN; NUTRITION; PATHOGENIC ESCHERICHIA COLI; PEPTOCLOSTRIDIUM DIFFICILE; PROTEOBACTERIA; REGULATORY T LYMPHOCYTE; REVIEW; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS; SYMBIOSIS; ANIMAL; BACTERIUM; COLORECTAL TUMOR; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY;

ANIMALS; BACTERIA; COLORECTAL NEOPLASMS; DYSBIOSIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PROBIOTICS;

EID: 84924529832     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/321241     Document Type: Review

References (324)

1. F. Bäckhed, R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon, "Host-bacterial mutualism in the human intestine," Science, Vol. 307, no. 5717, pp. 1915-1920, 2005.
2. C. A. Lozupone, J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight, "Diversity, stability and resilience of the human gut microbiota," Nature, Vol. 489, no. 7415, pp. 220-230, 2012.
3. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., "Diversity of the human intestinal microbial flora," Science, Vol. 308, no. 5728, pp. 1635-1638, 2005.
4. Human Microbiome Project C, "Structure, function and diversity of the healthy human microbiome," Nature, Vol. 486, pp. 207-214, 2012.
5. J. Qin, R. Li, J. Raes et al., "A human gut microbial gene catalogue established by metagenomic sequencing," Nature, Vol. 464, pp. 59-65, 2010.
6. A. Reyes, M. Haynes, N. Hanson et al., "Viruses in the faecal microbiota of monozygotic twins and their mothers," Nature, Vol. 466, no. 7304, pp. 334-338, 2010.
7. M. Arumugam, J. Raes, E. Pelletier et al., "Enterotypes of the human gut microbiome," Nature, Vol. 473, no. 7346, pp. 174-180, 2011.
8. J. J. Faith, J. L. Guruge, M. Charbonneau et al., "The long-term stability of the human gut microbiota," Science, Vol. 341, no. 6141, Article ID 1237439, 2013.
9. S. M. Lee, G. P. Donaldson, Z. Mikulski, S. Boyajian, K. Ley, and S. K. Mazmanian, "Bacterial colonization factors control specificity and stability of the gut microbiota," Nature, Vol. 501, no. 7467, pp. 426-429, 2013.
10. F. Araújo-Pérez, A. N. Mccoy, C. Okechukwu et al., "Differences in microbial signatures between rectal mucosal biopsies and rectal swabs," Gut Microbes, Vol. 3, no. 6, pp. 530-535, 2012.
11. R. J. Siezen and M. Kleerebezem, "The human gut microbiome: are we our enterotypes?" Microbial Biotechnology, Vol. 4, no. 5, pp. 550-553, 2011.
12. R. M. Torrazza and J. Neu, "The developing intestinal micro-biome and its relationship to health and disease in the neonate," Journal of Perinatology, Vol. 31, no. 1, pp. S29-S34, 2011.
13. M. G. Dominguez-Bello, E. K. Costello, M. Contreras et al., "Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 26, pp. 11971-11975, 2010.
14. E. J. Woodmansey, "Intestinal bacteria and ageing," Journal of Applied Microbiology, Vol. 102, no. 5, pp. 1178-1186, 2007.
15. A. M. Caricilli and M. J. A. Saad, "Gut microbiota composition and its effects on obesity and insulin resistance," Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 17, no. 4, pp. 312-318, 2014.
16. C. Polytarchou, G. Koukos, and D. Iliopoulos, "Systems biology in inflammatory bowel diseases: ready for prime time," Current Opinion in Gastroenterology, Vol. 30, no. 4, pp. 339-346, 2014.
17. T. Irrazábal, A. Belcheva, S. E. Girardin, A. Martin, and D. J. Philpott, "The multifaceted role of the intestinal microbiota in colon cancer," Molecular Cell, Vol. 54, no. 2, pp. 309-320, 2014.
18. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, "Longterm impacts of antibiotic exposure on the human intestinal microbiota," Microbiology, Vol. 156, no. 11, pp. 3216-3223, 2010.
19. C. de Filippo, D. Cavalieri, M. Di Paola et al., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 33, pp. 14691-14696, 2010.
20. G. D. Wu, J. Chen, C. Hoffmann et al., "Linking long-term dietary patterns with gut microbial enterotypes," Science, Vol. 334, no. 6052, pp. 105-108, 2011.
21. A. V. Tyakht, E. S. Kostryukova, A. S. Popenko et al., "Human gut microbiota community structures in urban and rural populations in Russia," Nature Communications, Vol. 4, article 2469, 2013.
22. J. J. Faith, N. P. McNulty, F. E. Rey, and J. I. Gordon, "Predicting a human gut microbiota's response to diet in gnotobiotic mice," Science, Vol. 333, no. 6038, pp. 101-104, 2011.
23. W. Fan, G. Huo, X. Li, L. Yang, and C. Duan, "Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life," Journal of Microbiology and Biotechnology, Vol. 24, no. 2, pp. 133-143, 2014.
24. P. J. Turnbaugh, V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight, and J. I. Gordon, "The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice," Science Translational Medicine, Vol. 1, no. 6, p. 6ra14, 2009.
25. L. A. David, C. F. Maurice, R. N. Carmody et al., "Diet rapidly and reproducibly alters the human gut microbiome," Nature, Vol. 505, no. 7484, pp. 559-563, 2014.
26. L. Cordain, S. B. Eaton, A. Sebastian et al., "Origins and evolution of the Western diet: health implications for the 21st century," American Journal of Clinical Nutrition, Vol. 81, no. 2, pp. 341-354, 2005.
27. S. Jew, S. S. Abumweis, and P. J. H. Jones, "Evolution of the human diet: Linking our ancestral diet to modern functional foods as a means of chronic disease prevention," Journal of Medicinal Food, Vol. 12, no. 5, pp. 925-934, 2009.
28. S. Macfarlane and G. T. Macfarlane, "Regulation of short-chain fatty acid production," Proceedings of the Nutrition Society, Vol. 62, pp. 67-72, 2003.
29. T. Hoverstad and T. Midtvedt, "Short-chain fatty acids in germfree mice and rats," Journal of Nutrition, Vol. 116, no. 9, pp. 1772-1776, 1986.
30. K. M. Maslowski, A. T. Vieira, A. Ng et al., "Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43," Nature, Vol. 461, no. 7268, pp. 1282-1286, 2009.
31. A. Trompette, E. S. Gollwitzer, K. Yadava et al., "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis," Nature Medicine, Vol. 20, no. 2, pp. 159-166, 2014.
32. V. R. Velagapudi, R. Hezaveh, C. S. Reigstad et al., "The gut microbiota modulates host energy and lipid metabolism in mice," Journal of Lipid Research, Vol. 51, no. 5, pp. 1101-1112, 2010.
33. F. Bäckhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage," Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, no. 44, pp. 15718-15723, 2004.
34. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest," Nature, Vol. 444, no. 7122, pp. 1027-1031, 2006.
35. P. J. Havel, "Role of adipose tissue in body-weight regulation: Mechanisms regulating leptin production and energy balance," The Proceedings of the Nutrition Society, Vol. 59, no. 3, pp. 359-371, 2000.
36. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, "Microbial ecology: Human gut microbes associated with obesity," Nature, Vol. 444, no. 7122, pp. 1022-1023, 2006.
37. R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, "Obesity alters gut microbial ecology," Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, no. 31, pp. 11070-11075, 2005.
38. V. K. Ridaura, J. J. Faith, F. E. Rey et al., "Gut microbiota from twins discordant for obesity modulate metabolism in mice," Science, Vol. 341, no. 6150, Article ID 1241214, 2013.
39. K.-J. Rhee, P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight, "Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire," The Journal of Immunology, Vol. 172, no. 2, pp. 1118-1124, 2004.
40. J. Chow, S. M. Lee, Y. Shen, A. Khosravi, and S. K. Mazmanian, "Host-bacterial symbiosis in health and disease," Advances in Immunology, Vol. 107, pp. 243-274, 2010.
41. N. Kamada, S.-U. Seo, G. Y. Chen, and G. Núñez, "Role of the gut microbiota in immunity and inflammatory disease," Nature Reviews Immunology, Vol. 13, no. 5, pp. 321-335, 2013.
42. E. Gueguen and E. Cascales, "Promoter swapping unveils the role of the Citrobacter rodentium CTS1 type VI secretion system in interbacterial competition," Applied and Environmental Microbiology, Vol. 79, no. 1, pp. 32-38, 2013.
43. J. M. Wells, O. Rossia, M. Meijerink, and P. van Baarlen, "Epithelial crosstalk at the microbiota-mucosal interface," Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, no. 1, pp. 4607-4614, 2011.
44. I. D. Iliev, E. Mileti, G. Matteoli, M. Chieppa, and M. Rescigno, "Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning," Mucosal Immunology, Vol. 2, no. 4, pp. 340-350, 2009.
45. +, antigen sampling cells migrate in lymph and serve classical dendritic cell functions," Journal of Experimental Medicine, Vol. 206, no. 13, pp. 3101-3114, 2009.
46. + dendritic cells in the small intestine," Nature, Vol. 483, no. 7389, pp. 345-349, 2012.
47. V. Gaboriau-Routhiau, S. Rakotobe, E. Lécuyer et al., "The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses," Immunity, Vol. 31, no. 4, pp. 677-689, 2009.
48. S. K. Mazmanian, J. L. Round, and D. L. Kasper, "A microbial symbiosis factor prevents intestinal inflammatory disease," Nature, Vol. 453, no. 7195, pp. 620-625, 2008.
49. K. Atarashi, T. Tanoue, T. Shima et al., "Induction of colonic regulatory T cells by indigenous Clostridium species," Science, Vol. 331, no. 6015, pp. 337-341, 2011.
50. Y. K. Lee and S. K. Mazmanian, "Has the microbiota played a critical role in the evolution of the adaptive immune system?" Science, Vol. 330, no. 6012, pp. 1768-1773, 2010.
51. A. Mortha, A. Chudnovskiy, D. Hashimoto et al., "Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis," Science, Vol. 343, no. 6178, Article ID 1249288, 2014.
52. + cells," Nature Immunology, Vol. 10, no. 1, pp. 83-91, 2009.
53. S. Vaishnava, M. Yamamoto, K. M. Severson et al., "The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine," Science, Vol. 334, no. 6053, pp. 255-258, 2011.
54. + T cells in inflammatory bowel disease and colon cancer," Clinical Immunology, Vol. 148, no. 2, pp. 246-253, 2013.
55. + regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients," inflammatory Bowel Diseases, Vol. 19, no. 12, pp. 2522-2534, 2013.
56. + dendritic cells," European Journal of Immunology, Vol. 40, no. 7, pp. 1877-1883, 2010.
57. G. R. Corey, H. Kabler, P. Mehra et al., "Single-Dose oritavancin in the treatment of acute bacterial skin infections," The New England Journal of Medicine, Vol. 370, no. 23, pp. 2180-2190, 2014.
58. N. Kardos and A. L. Demain, "Penicillin: the medicine with the greatest impact on therapeutic outcomes," Applied Microbiology and Biotechnology, Vol. 92, no. 4, pp. 677-687, 2011.
59. M.-J. Nurfahzura, H. Hanizasurana, E. Zunaina, and H. Adil, "Successful treatment of syphilitic uveitis in HIV-positive patients," Clinical Ophthalmology, Vol. 7, pp. 1651-1654, 2013.
60. S. Koido, T. Ohkusa, T. Kajiura et al., "Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy," PLoS ONE, Vol. 9, no. 1, Article ID e86702, 2014.
61. M. Wlodarska, B. Willing, K. M. Keeney et al., "Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis," Infection and Immunity, Vol. 79, no. 4, pp. 1536-1545, 2011.
62. C. Högenauer, C. Langner, E. Beubler et al., "Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis," The New England Journal of Medicine, Vol. 355, no. 23, pp. 2418-2426, 2006.
63. D. van der Waaij and J. M. Berghuis-de Vries, "Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.," Journal of Hygiene, Vol. 69, no. 3, pp. 405-411, 1971.
64. R. Freter, "Experimental enteric Shigella and Vibrio infections in mice and guinea pigs," The Journal of Experimental Medicine, Vol. 104, pp. 411-418, 1956.
65. D. J. Hentges, A. J. Stein, S. W. Casey, and J. U. Que, "Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance," Infection and Immunity, Vol. 47, no. 1, pp. 118-122, 1985.
66. J. U. Que and D. J. Hentges, "Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice," Infection and Immunity, Vol. 48, no. 1, pp. 169-174, 1985.
67. K. Itoh and R. Freter, "Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures," Infection and Immunity, Vol. 57, no. 2, pp. 559-565, 1989.
68. B. Stecher, A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach, and W.-D. Hardt, "Comparison of Salmonella enterica serovar typhimurium colitis in germfree mice and mice pretreated with streptomycin," Infection and Immunity, Vol. 73, no. 6, pp. 3228-3241, 2005.
69. C. T. Fagundes, F. A. Amaral, A. T. Vieira et al., "Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice," The Journal of Immunology, Vol. 188, no. 3, pp. 1411-1420, 2012.
70. I. I. Ivanov, K. Atarashi, N. Manel et al., "Induction of intestinal Th17 cells by segmented filamentous bacteria," Cell, Vol. 139, no. 3, pp. 485-498, 2009.
71. S. Vaishnava, C. L. Behrendt, A. S. Ismail, L. Eckmann, and L. V. Hooper, "Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface," Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, no. 52, pp. 20858-20863, 2008.
72. R. Ducluzeau, F. Dubos, and P. G. D. Raibaud and Abrams, "Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract," Antimicrobial Agents and Chemotherapy, Vol. 9, no. 1, pp. 20-25, 1976.
73. M. C. Rea, E. Clayton, P. M. O'Connor et al., "Antimicrobial activity of lacticin 3147 against clinical Clostridium dificile strains," Journal of Medical Microbiology, Vol. 56, no. 7, pp. 940-946, 2007.
74. M. C. Rea, C. S. Sit, E. Clayton et al., "Thuricin CD, a post-translationally modified bacteriocin with a narrow spectrum of activity against Clostridium dificile," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 20, pp. 9352-9357, 2010.
75. M. M. Heimesaat, A. Fischer, H.-K. Jahn et al., "Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli," Gut, Vol. 56, no. 7, pp. 941-948, 2007.
76. B. Stecher, R. Robbiani, A. W. Walker et al., "Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota," PLoS Biology, Vol. 5, no. 10, pp. 2177-2189, 2007.
77. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 27, pp. 12204-12209, 2010.
78. D. A. Hill and D. Artis, "Intestinal bacteria and the regulation of immune cell homeostasis," Annual Review of Immunology, Vol. 28, pp. 623-667, 2010.
79. M. M. Heimesaat, S. Bereswill, A. Fischer et al., "Gramnegative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii," Journal of Immunology, Vol. 177, no. 12, pp. 8785-8795, 2006.
80. T. Hand and Y. Belkaid, "Microbial control of regulatory and effector T cell responses in the gut," Current Opinion in Immunology, Vol. 22, no. 1, pp. 63-72, 2010.
81. J. M. Brenchley, D. A. Price, T. W. Schacker et al., "Microbial translocation is a cause of systemic immune activation in chronic HIV infection," Nature Medicine, Vol. 12, no. 12, pp. 1365-1371, 2006.
82. N. G. Sandler and D. C. Douek, "Microbial translocation in HIV infection: causes, consequences and treatment opportunities," Nature Reviews Microbiology, Vol. 10, no. 9, pp. 655-666, 2012.
83. I. Vujkovic-Cvijin, R. M. Dunham, S. Iwai et al., "Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism," Science Translational Medicine, Vol. 5, no. 193, Article ID 193ra91, 2013.
84. U. Hofer, E. Schlaepfer, S. Baenziger et al., "Inadequate clearance of translocated bacterial products in HIV-infected humanized mice," PLoS Pathogens, Vol. 6, no. 4, Article ID e1000867, 2010.
85. J. Henao-Mejia, E. Elinav, C. Jin et al., "Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity," Nature, Vol. 482, no. 7384, pp. 179-185, 2012.
86. K. Schroder and J. Tschopp, "The Inflammasomes," Cell, Vol. 140, no. 6, pp. 821-832, 2010.
87. M. L. Balmer, E. Slack, A. de Gottardi et al., "The liver may act as a frewall mediating mutualism between the host and its gut commensal microbiota," Science Translational Medicine, Vol. 6, no. 237, Article ID 237ra66, 2014.
88. J. Qin, Y. Li, Z. Cai, and et al, "A metagenome-wide association study of gut microbiota in type 2 diabetes," Nature, Vol. 490, no. 7418, pp. 55-60, 2012.
89. D. Gevers, S. Kugathasan, L. A. Denson et al., "The treatment-naive microbiome in new-onset Crohn's disease," Cell Host & Microbe, Vol. 15, pp. 382-392, 2014.
90. E. Papa, M. Docktor, C. Smillie et al., "Non-invasive mapping of the gastrointestinal microbiota identifies children with inflam-matory bowel disease," PLoS ONE, Vol. 7, no. 6, Article ID e39242, 2012.
91. S. E. Winter and A. J. Baumler, "Dysbiosis in the inflamed intestine: chance favors the prepared microbe," Gut Microbes, Vol. 5, no. 1, pp. 71-73, 2014.
92. B. Stecher, R. Denzler, L. Maier et al., "Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae," Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, no. 4, pp. 1269-1274, 2012.
93. + regulatory T cells in the lamina propria," Immunity, Vol. 34, no. 2, pp. 237-246, 2011.
94. C. O'Mahony, P. Scully, D. O'Mahony et al., "Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation," PLoS Pathogens, Vol. 4, no. 8, Article ID e1000112, 2008.
95. I. R. Cohen and L. C. Norins, "Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M," Science, Vol. 152, no. 3726, pp. 1257-1259, 1966.
96. G. P. Manukyan, K. A. Ghazaryan, Z. A. Ktsoyan et al., "Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition," PLoS ONE, Vol. 3, no. 9, Article ID e3172, 2008.
97. H. Scott, T. O. Rognum, T. Midtvedt, and P. Brandtzaeg, "Age-related changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzyme-linked immunosorbent assay," Acta Pathologica Microbiologica et Immunologica Scandinavica C: Immunology, Vol. 93, no. 2, pp. 65-70, 1985.
98. A. Haas, K. Zimmermann, F. Graw et al., "Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection," Gut, Vol. 60, no. 11, pp. 1506-1519, 2011.
99. V. Pascual, R. Dieli-Crimi, N. López-Palacios, A. Bodas, L. M. Medrano, and C. Núñez, "inflammatory bowel disease and celiac disease: overlaps and differences," World Journal of Gastroenterology, Vol. 20, no. 17, pp. 4846-4856, 2014.
100. J. Ezri, P. Marques-Vidal, and A. Nydegger, "Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease," Digestion, Vol. 85, no. 4, pp. 308-319, 2012.
101. D. Comito, A. Cascio, and C. Romano, "Microbiota biodiversity in inflammatory bowel disease," Italian Journal of Pediatrics, Vol. 40, no. 1, article 32, 2014.
102. J. R. Allegretti and M. J. Hamilton, "Restoring the gut micro-biome for the treatment of inflammatory bowel diseases," World Journal of Gastroenterology, Vol. 20, no. 13, pp. 3468-3474, 2014.
103. D. Corridoni, K. O. Arseneau, M. G. Cifone et al., "The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation," Frontiers in Immunology, Vol. 5, article 317, 2014.
104. J. Z. Liu and C. A. Anderson, "Genetic studies of Crohn's disease: past, present and future," Best Practice & Research Clinical Gastroenterology, Vol. 28, no. 3, pp. 373-386, 2014.
105. H. zur Hausen, "The search for infectious causes of human cancers: where and why," Virolog y, Vol. 392, no. 1, pp. 1-10, 2009.
106. I. Lee, "Critical pathogenic steps to high risk gastritis and gastric carcinogenesis," World Journal of Gastroenterology, Vol. 20, pp. 6412-6419, 2014.
107. N. Wu, X. Yang, R. Zhang et al., "Dysbiosis signature of fecal microbiota in colorectal cancer patients," Microbial Ecology, Vol. 66, no. 2, pp. 462-470, 2013.
108. T. Wang, G. Cai, Y. Qiu et al., "Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers," The ISME Journal, Vol. 6, no. 2, pp. 320-329, 2012.
109. N. U. Toprak, A. Yagci, B. M. Gulluoglu et al., "A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer," Clinical Microbiology and Infection, Vol. 12, no. 8, pp. 782-786, 2006.
110. T. P. Prindiville, R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva Jr., "Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease," Emerging Infectious Diseases, Vol. 6, no. 2, pp. 171-174, 2000.
111. C. Basset, J. Holton, A. Bazeos, D. Vaira, and S. Bloom, "Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?" Digestive Diseases and Sciences, Vol. 49, no. 9, pp. 1425-1432, 2004.
112. J. M. Kim, Y. K. Oh, Y. J. Kim, H. B. Oh, and Y. J. Cho, "Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-κB plays a major role in the regulation of IL-8 expression," Clinical and Experimental Immunology, Vol. 123, no. 3, pp. 421-427, 2001.
113. L. Sanfilippo, C. K. F. Li, R. Seth, T. J. Balwin, M. G. Menozzi, and Y. R. Mahida, "Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-β) by human colonic epithelial cells," Clinical and Experimental Immunology, Vol. 119, no. 3, pp. 456-463, 2000.
114. S. Wu, J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears, "Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway," Infection and Immunity, Vol. 72, no. 10, pp. 5832-5839, 2004.
115. S. Wu, P. J. Morin, D. Maouyo, and C. L. Sears, "Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation," Gastroenterology, Vol. 124, no. 2, pp. 392-400, 2003.
116. J. C. Arthur, E. Perez-Chanona, M. Mühlbauer et al., "Intestinal inflammation targets cancer-inducing activity of the micro-biota," Science, Vol. 338, no. 6103, pp. 120-123, 2012.
117. S. Umar, "Citrobacter infection and wnt signaling," Current Colorectal Cancer Reports, Vol. 8, no. 4, pp. 298-306, 2012.
118. H. Zeng, A. Q. Carlson, Y. Guo et al., "Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella," Journal of Immunology, Vol. 171, no. 7, pp. 3668-3674, 2003.
119. Y. C. Ju, D. A. Antonopoulos, A. Kalra et al., "Decreased diversity of the fecal microbiome in recurrent Clostridium dificile-associated diarrhea," Journal of Infectious Diseases, Vol. 197, no. 3, pp. 435-438, 2008.
120. M. A. Bisi-Johnson, C. L. Obi, S. D. Vasaikar, K. A. Baba, and T. Hattori, "Molecular basis of virulence in clinical isolates of Escherichia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South Africa," Gut Pathogens, Vol. 3, no. 1, article 9, 2011.
121. C. D. Garner, D. A. Antonopoulos, B. Wagner et al., "Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection," Infection and Immunity, Vol. 77, no. 7, pp. 2691-2702, 2009.
122. A. Croswell, E. Amir, P. Teggatz, M. Barman, and N.H. Salzman, "Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection," Infection and Immunity, Vol. 77, no. 7, pp. 2741-2753, 2009.
123. G. M. Pupo, D. K. R. Karaolis, R. Lan, and P. R. Reeves, "Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme elec-trophoresis and mdh sequence studies," Infection and Immunity, Vol. 65, no. 7, pp. 2685-2692, 1997.
124. J. Garmendia, G. Frankel, and V. F. Crepin, "Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation," Infection and Immunity, Vol. 73, no. 5, pp. 2573-2585, 2005.
125. S. Fukuda, H. Toh, K. Hase et al., "Bifidobacteria can protect from enteropathogenic infection through production of acetate," Nature, Vol. 469, no. 7331, pp. 543-547, 2011.
126. R. Maltby, M. P. Leatham-Jensen, T. Gibson, P. S. Cohen, and T. Conway, "Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine," PLoS ONE, Vol. 8, no. 1, Article ID e53957, 2013.
127. N. Kamada, Y.-G. Kim, H. P. Sham et al., "Regulated virulence controls the ability of a pathogen to compete with the gut microbiota," Science, Vol. 336, no. 6086, pp. 1325-1329, 2012.
128. + cells that provide innate mucosal immune defense," Immunity, Vol. 29, no. 6, pp. 958-970, 2008.
129. V. Shankar, M. J. Hamilton, A. Khoruts et al., "Species and genus level resolution analysis of gut microbiota in Clostridium dificile patients following fecal microbiota transplantation," Microbiome, Vol. 2, article 13, 2014.
130. C. Seretis, F. Seretis, and K. Goonetilleke, "Appendicectomy and Clostridium dificile infection: is there a link?" Journal of Clinical Medicine Research, Vol. 6, pp. 239-241, 2014.
131. K. E. Burke and J. T. Lamont, "Clostridium dificile infection: a worldwide disease," Gut and Liver, Vol. 8, no. 1, pp. 1-6, 2014.
132. M. Medina, E. Izquierdo, S. Ennahar, and Y. Sanz, "Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications," Clinical & Experimental Immunology, Vol. 150, no. 3, pp. 531-538, 2007.
133. I. Hojsak, N. Snovak, S. Abdović, H. Szajewska, Z. Mišak, and S. Kolaček, "Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial," Clinical Nutrition, Vol. 29, no. 3, pp. 312-316, 2010.
134. N. P. McNulty, T. Yatsunenko, A. Hsiao et al., "The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins," Science Translational Medicine, Vol. 3, no. 106, Article ID 106ra106, 2011.
135. P. Veiga, C. A. Gallini, C. Beal et al., "Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 42, pp. 18132-18137, 2010.
136. A. T. Vieira, M. M. Teixeira, and F. S. Martins, "The role of probiotics and prebiotics in inducing gut immunity," Frontiers in Immunology, Vol. 4, article 445, 2013.
137. S. C. Corr, Y. Li, C. U. Riedel, P. W. O'Toole, C. Hill, and C. G. M. Gahan, "Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118," Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, no. 18, pp. 7617-7621, 2007.
138. F. S. Martins, G. Dalmasso, R. M. E. Arantes et al., "Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection," PLoS ONE, Vol. 5, no. 1, Article ID e8925, 2010.
139. S. Lebeer, J. Vanderleyden, and S. C. J. de Keersmaecker, "Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens," Nature Reviews Microbiology, Vol. 8, no. 3, pp. 171-184, 2010.
140. R. Mohan, C. Koebnick, J. Schildt, M. Mueller, M. Radke, and M. Blaut, "Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants," Pediatric Research, Vol. 64, no. 4, pp. 418-422, 2008.
141. F. S. Martins, A. T. Vieira, S. D. A. Elian et al., "Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice," Microbes and Infection, Vol. 15, no. 4, pp. 270-279, 2013.
142. P. W. Lin, L. E. S. Myers, L. Ray et al., "Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation," Free Radical Biology and Medicine, Vol. 47, no. 8, pp. 1205-1211, 2009.
143. C. Dai, C.-Q. Zheng, F.-J. Meng, Z. Zhou, L.-X. Sang, and M. Jiang, "VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis," Molecular and Cellular Biochemistry, Vol. 374, no. 1-2, pp. 1-11, 2013.
144. L. M. dos Santos, M. M. Santos, H. P. de Souza Silva, R. M. E. Arantes, J. R. Nicoli, and L. Q. Vieira, "Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection," Medical Microbiology and Immunology, Vol. 200, no. 1, pp. 29-38, 2011.
145. J. Bassaganya-Riera, M. Viladomiu, M. Pedragosa, C. de Simone, and R. Hontecillas, "Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria," PloS ONE, Vol. 7, no. 4, Article ID e34676, 2012.
146. A. Hayashi, T. Sato, N. Kamada et al., "A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice," Cell Host and Microbe, Vol. 13, no. 6, pp. 711-722, 2013.
147. G. R. D'Haens, R. B. Sartor, M. S. Silverberg, J. Petersson, and P. Rutgeerts, "Future directions in inflammatory bowel disease management," Journal of Crohn's and Colitis, Vol. 8, no. 8, pp. 726-734, 2014.
148. G. R. Veerappan, J. Betteridge, and P. E. Young, "Probiotics for the treatment of inflammatory bowel disease," Current Gastroenterology Reports, Vol. 14, no. 4, pp. 324-333, 2012.
149. E. Park, G.-I. Jeon, J.-S. Park, and H.-D. Paik, "A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat," Biological and Pharmaceutical Bulletin, Vol. 30, no. 3, pp. 569-574, 2007.
150. Y. Kim, D. Lee, D. Kim et al., "Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212," Archives of Pharmacal Research, Vol. 31, no. 4, pp. 468-473, 2008.
151. R. Satish Kumar, P. Kanmani, N. Yuvaraj et al., "Lactobacillus plantarum AS1 isolated from South Indian fermented food Kallappam suppress 1, 2-dimethyl hydrazine (DMH)-induced colorectal cancer in male wistar rats," Applied Biochemistry and Biotechnology, Vol. 166, no. 3, pp. 620-631, 2012.
152. V. Pala, S. Sieri, F. Berrino et al., "Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort," International Journal of Cancer, Vol. 129, no. 11, pp. 2712-2719, 2011.
153. N. B. O. Corrêa, F. J. Penna, F. M. L. S. Lima, J. R. Nicoli, and L. A. P. Filho, "Treatment of acute diarrhea with saccharomyces boulardii in infants," Journal of Pediatric Gastroenterology and Nutrition, Vol. 53, no. 5, pp. 497-501, 2011.
154. H. Szajewska, A. Skorka, M. Ruszczynski, and D. Gieruszczak-Białek, "Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials," Alimentary Pharmacology and Therapeutics, Vol. 38, no. 5, pp. 467-476, 2013.
155. N. B. Corrêa, L. A. Péret Filho, F. J. Penna, F. M. L. S. Lima, and J. R. Nicoli, "A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants," Journal of Clinical Gastroenterology, Vol. 39, no. 5, pp. 385-389, 2005.
156. M. K. Salminen, S. Tynkkynen, H. Rautelin et al., "Lactobacillus bacteremia during a rapid increase in probiotic use of Lacto-bacillus rhamnosus GG in Finland," Clinical Infectious Diseases, Vol. 35, no. 10, pp. 1155-1160, 2002.
157. T. Lherm, C. Monet, B. Nougière et al., "Seven cases of fungemia with Saccharomyces boulardii in critically ill patients," Intensive Care Medicine, Vol. 28, no. 6, pp. 797-801, 2002.
158. S. Cesaro, P. Chinello, L. Rossi, and L. Zanesco, "Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii," Supportive Care in Cancer, Vol. 8, no. 6, pp. 504-505, 2000.
159. A. N. Kunz, J. M. Noel, and M. P. Fairchok, "Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome," Journal of Pediatric Gastroenterology and Nutrition, Vol. 38, no. 4, pp. 457-458, 2004.
160. E. Connolly, T. Abrahamsson, and B. Björkstén, "Safety of D(-)-lactic acid producing bacteria in the human infant," Journal of Pediatric Gastroenterology and Nutrition, Vol. 41, no. 4, pp. 489-492, 2005.
161. P. Kochan, A. Chmielarczyk, L. Szymaniak et al., "Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient-is the time right to revise probiotic safety guidelines?" Clinical Microbiology and Infection, Vol. 17, no. 10, pp. 1589-1592, 2011.
162. M. Egervärn, H. Lindmark, J. Olsson, and S. Roos, "Trans-ferability of a tetracycline resistance gene from probiotic Lac-tobacillus reuteri to bacteria in the gastrointestinal tract of humans," Antonie van Leeuwenhoek, Vol. 97, no. 2, pp. 189-200, 2010.
163. F. Bäckhed, R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon, "Host-bacterial mutualism in the human intestine," Science, Vol. 307, no. 5717, pp. 1915-1920, 2005.
164. C. A. Lozupone, J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight, "Diversity, stability and resilience of the human gut microbiota," Nature, Vol. 489, no. 7415, pp. 220-230, 2012.
165. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., "Diversity of the human intestinal microbial flora," Science, Vol. 308, no. 5728, pp. 1635-1638, 2005.
166. Human Microbiome Project C, "Structure, function and diversity of the healthy human microbiome," Nature, Vol. 486, pp. 207-214, 2012.
167. J. Qin, R. Li, J. Raes et al., "A human gut microbial gene catalogue established by metagenomic sequencing," Nature, Vol. 464, pp. 59-65, 2010.
168. A. Reyes, M. Haynes, N. Hanson et al., "Viruses in the faecal microbiota of monozygotic twins and their mothers," Nature, Vol. 466, no. 7304, pp. 334-338, 2010.
169. M. Arumugam, J. Raes, E. Pelletier et al., "Enterotypes of the human gut microbiome," Nature, Vol. 473, no. 7346, pp. 174-180, 2011.
170. J. J. Faith, J. L. Guruge, M. Charbonneau et al., "The long-term stability of the human gut microbiota," Science, Vol. 341, no. 6141, Article ID 1237439, 2013.
171. S. M. Lee, G. P. Donaldson, Z. Mikulski, S. Boyajian, K. Ley, and S. K. Mazmanian, "Bacterial colonization factors control specificity and stability of the gut microbiota," Nature, Vol. 501, no. 7467, pp. 426-429, 2013.
172. F. Araújo-Pérez, A. N. Mccoy, C. Okechukwu et al., "Differences in microbial signatures between rectal mucosal biopsies and rectal swabs," Gut Microbes, Vol. 3, no. 6, pp. 530-535, 2012.
173. R. J. Siezen and M. Kleerebezem, "The human gut microbiome: are we our enterotypes?" Microbial Biotechnology, Vol. 4, no. 5, pp. 550-553, 2011.
174. R. M. Torrazza and J. Neu, "The developing intestinal micro-biome and its relationship to health and disease in the neonate," Journal of Perinatology, Vol. 31, no. 1, pp. S29-S34, 2011.
175. M. G. Dominguez-Bello, E. K. Costello, M. Contreras et al., "Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 26, pp. 11971-11975, 2010.
176. E. J. Woodmansey, "Intestinal bacteria and ageing," Journal of Applied Microbiology, Vol. 102, no. 5, pp. 1178-1186, 2007.
177. A. M. Caricilli and M. J. A. Saad, "Gut microbiota composition and its effects on obesity and insulin resistance," Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 17, no. 4, pp. 312-318, 2014.
178. C. Polytarchou, G. Koukos, and D. Iliopoulos, "Systems biology in inflammatory bowel diseases: ready for prime time," Current Opinion in Gastroenterology, Vol. 30, no. 4, pp. 339-346, 2014.
179. T. Irrazábal, A. Belcheva, S. E. Girardin, A. Martin, and D. J. Philpott, "The multifaceted role of the intestinal microbiota in colon cancer," Molecular Cell, Vol. 54, no. 2, pp. 309-320, 2014.
180. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, "Longterm impacts of antibiotic exposure on the human intestinal microbiota," Microbiology, Vol. 156, no. 11, pp. 3216-3223, 2010.
181. C. de Filippo, D. Cavalieri, M. Di Paola et al., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 33, pp. 14691-14696, 2010.
182. G. D. Wu, J. Chen, C. Hoffmann et al., "Linking long-term dietary patterns with gut microbial enterotypes," Science, Vol. 334, no. 6052, pp. 105-108, 2011.
183. A. V. Tyakht, E. S. Kostryukova, A. S. Popenko et al., "Human gut microbiota community structures in urban and rural populations in Russia," Nature Communications, Vol. 4, article 2469, 2013.
184. J. J. Faith, N. P. McNulty, F. E. Rey, and J. I. Gordon, "Predicting a human gut microbiota's response to diet in gnotobiotic mice," Science, Vol. 333, no. 6038, pp. 101-104, 2011.
185. W. Fan, G. Huo, X. Li, L. Yang, and C. Duan, "Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life," Journal of Microbiology and Biotechnology, Vol. 24, no. 2, pp. 133-143, 2014.
186. P. J. Turnbaugh, V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight, and J. I. Gordon, "The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice," Science Translational Medicine, Vol. 1, no. 6, p. 6ra14, 2009.
187. L. A. David, C. F. Maurice, R. N. Carmody et al., "Diet rapidly and reproducibly alters the human gut microbiome," Nature, Vol. 505, no. 7484, pp. 559-563, 2014.
188. L. Cordain, S. B. Eaton, A. Sebastian et al., "Origins and evolution of the Western diet: health implications for the 21st century," American Journal of Clinical Nutrition, Vol. 81, no. 2, pp. 341-354, 2005.
189. S. Jew, S. S. Abumweis, and P. J. H. Jones, "Evolution of the human diet: Linking our ancestral diet to modern functional foods as a means of chronic disease prevention," Journal of Medicinal Food, Vol. 12, no. 5, pp. 925-934, 2009.
190. S. Macfarlane and G. T. Macfarlane, "Regulation of short-chain fatty acid production," Proceedings of the Nutrition Society, Vol. 62, pp. 67-72, 2003.
191. T. Hoverstad and T. Midtvedt, "Short-chain fatty acids in germfree mice and rats," Journal of Nutrition, Vol. 116, no. 9, pp. 1772-1776, 1986.
192. K. M. Maslowski, A. T. Vieira, A. Ng et al., "Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43," Nature, Vol. 461, no. 7268, pp. 1282-1286, 2009.
193. A. Trompette, E. S. Gollwitzer, K. Yadava et al., "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis," Nature Medicine, Vol. 20, no. 2, pp. 159-166, 2014.
194. V. R. Velagapudi, R. Hezaveh, C. S. Reigstad et al., "The gut microbiota modulates host energy and lipid metabolism in mice," Journal of Lipid Research, Vol. 51, no. 5, pp. 1101-1112, 2010.
195. F. Bäckhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage," Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, no. 44, pp. 15718-15723, 2004.
196. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest," Nature, Vol. 444, no. 7122, pp. 1027-1031, 2006.
197. P. J. Havel, "Role of adipose tissue in body-weight regulation: Mechanisms regulating leptin production and energy balance," The Proceedings of the Nutrition Society, Vol. 59, no. 3, pp. 359-371, 2000.
198. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, "Microbial ecology: Human gut microbes associated with obesity," Nature, Vol. 444, no. 7122, pp. 1022-1023, 2006.
199. R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, "Obesity alters gut microbial ecology," Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, no. 31, pp. 11070-11075, 2005.
200. V. K. Ridaura, J. J. Faith, F. E. Rey et al., "Gut microbiota from twins discordant for obesity modulate metabolism in mice," Science, Vol. 341, no. 6150, Article ID 1241214, 2013.
201. K.-J. Rhee, P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight, "Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire," The Journal of Immunology, Vol. 172, no. 2, pp. 1118-1124, 2004.
202. J. Chow, S. M. Lee, Y. Shen, A. Khosravi, and S. K. Mazmanian, "Host-bacterial symbiosis in health and disease," Advances in Immunology, Vol. 107, pp. 243-274, 2010.
203. N. Kamada, S.-U. Seo, G. Y. Chen, and G. Núñez, "Role of the gut microbiota in immunity and inflammatory disease," Nature Reviews Immunology, Vol. 13, no. 5, pp. 321-335, 2013.
204. E. Gueguen and E. Cascales, "Promoter swapping unveils the role of the Citrobacter rodentium CTS1 type VI secretion system in interbacterial competition," Applied and Environmental Microbiology, Vol. 79, no. 1, pp. 32-38, 2013.
205. J. M. Wells, O. Rossia, M. Meijerink, and P. van Baarlen, "Epithelial crosstalk at the microbiota-mucosal interface," Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, no. 1, pp. 4607-4614, 2011.
206. I. D. Iliev, E. Mileti, G. Matteoli, M. Chieppa, and M. Rescigno, "Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning," Mucosal Immunology, Vol. 2, no. 4, pp. 340-350, 2009.
207. +, antigen sampling cells migrate in lymph and serve classical dendritic cell functions," Journal of Experimental Medicine, Vol. 206, no. 13, pp. 3101-3114, 2009.
208. + dendritic cells in the small intestine," Nature, Vol. 483, no. 7389, pp. 345-349, 2012.
209. V. Gaboriau-Routhiau, S. Rakotobe, E. Lécuyer et al., "The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses," Immunity, Vol. 31, no. 4, pp. 677-689, 2009.
210. S. K. Mazmanian, J. L. Round, and D. L. Kasper, "A microbial symbiosis factor prevents intestinal inflammatory disease," Nature, Vol. 453, no. 7195, pp. 620-625, 2008.
211. K. Atarashi, T. Tanoue, T. Shima et al., "Induction of colonic regulatory T cells by indigenous Clostridium species," Science, Vol. 331, no. 6015, pp. 337-341, 2011.
212. Y. K. Lee and S. K. Mazmanian, "Has the microbiota played a critical role in the evolution of the adaptive immune system?" Science, Vol. 330, no. 6012, pp. 1768-1773, 2010.
213. A. Mortha, A. Chudnovskiy, D. Hashimoto et al., "Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis," Science, Vol. 343, no. 6178, Article ID 1249288, 2014.
214. + cells," Nature Immunology, Vol. 10, no. 1, pp. 83-91, 2009.
215. S. Vaishnava, M. Yamamoto, K. M. Severson et al., "The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine," Science, Vol. 334, no. 6053, pp. 255-258, 2011.
216. + T cells in inflammatory bowel disease and colon cancer," Clinical Immunology, Vol. 148, no. 2, pp. 246-253, 2013.
217. + regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients," inflammatory Bowel Diseases, Vol. 19, no. 12, pp. 2522-2534, 2013.
218. + dendritic cells," European Journal of Immunology, Vol. 40, no. 7, pp. 1877-1883, 2010.
219. G. R. Corey, H. Kabler, P. Mehra et al., "Single-Dose oritavancin in the treatment of acute bacterial skin infections," The New England Journal of Medicine, Vol. 370, no. 23, pp. 2180-2190, 2014.
220. N. Kardos and A. L. Demain, "Penicillin: the medicine with the greatest impact on therapeutic outcomes," Applied Microbiology and Biotechnology, Vol. 92, no. 4, pp. 677-687, 2011.
221. M.-J. Nurfahzura, H. Hanizasurana, E. Zunaina, and H. Adil, "Successful treatment of syphilitic uveitis in HIV-positive patients," Clinical Ophthalmology, Vol. 7, pp. 1651-1654, 2013.
222. S. Koido, T. Ohkusa, T. Kajiura et al., "Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy," PLoS ONE, Vol. 9, no. 1, Article ID e86702, 2014.
223. M. Wlodarska, B. Willing, K. M. Keeney et al., "Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis," Infection and Immunity, Vol. 79, no. 4, pp. 1536-1545, 2011.
224. C. Högenauer, C. Langner, E. Beubler et al., "Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis," The New England Journal of Medicine, Vol. 355, no. 23, pp. 2418-2426, 2006.
225. D. van der Waaij and J. M. Berghuis-de Vries, "Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.," Journal of Hygiene, Vol. 69, no. 3, pp. 405-411, 1971.
226. R. Freter, "Experimental enteric Shigella and Vibrio infections in mice and guinea pigs," The Journal of Experimental Medicine, Vol. 104, pp. 411-418, 1956.
227. D. J. Hentges, A. J. Stein, S. W. Casey, and J. U. Que, "Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance," Infection and Immunity, Vol. 47, no. 1, pp. 118-122, 1985.
228. J. U. Que and D. J. Hentges, "Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice," Infection and Immunity, Vol. 48, no. 1, pp. 169-174, 1985.
229. K. Itoh and R. Freter, "Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures," Infection and Immunity, Vol. 57, no. 2, pp. 559-565, 1989.
230. B. Stecher, A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach, and W.-D. Hardt, "Comparison of Salmonella enterica serovar typhimurium colitis in germfree mice and mice pretreated with streptomycin," Infection and Immunity, Vol. 73, no. 6, pp. 3228-3241, 2005.
231. C. T. Fagundes, F. A. Amaral, A. T. Vieira et al., "Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice," The Journal of Immunology, Vol. 188, no. 3, pp. 1411-1420, 2012.
232. I. I. Ivanov, K. Atarashi, N. Manel et al., "Induction of intestinal Th17 cells by segmented filamentous bacteria," Cell, Vol. 139, no. 3, pp. 485-498, 2009.
233. S. Vaishnava, C. L. Behrendt, A. S. Ismail, L. Eckmann, and L. V. Hooper, "Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface," Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, no. 52, pp. 20858-20863, 2008.
234. R. Ducluzeau, F. Dubos, and P. G. D. Raibaud and Abrams, "Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract," Antimicrobial Agents and Chemotherapy, Vol. 9, no. 1, pp. 20-25, 1976.
235. M. C. Rea, E. Clayton, P. M. O'Connor et al., "Antimicrobial activity of lacticin 3147 against clinical Clostridium dificile strains," Journal of Medical Microbiology, Vol. 56, no. 7, pp. 940-946, 2007.
236. M. C. Rea, C. S. Sit, E. Clayton et al., "Thuricin CD, a post-translationally modified bacteriocin with a narrow spectrum of activity against Clostridium dificile," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 20, pp. 9352-9357, 2010.
237. M. M. Heimesaat, A. Fischer, H.-K. Jahn et al., "Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli," Gut, Vol. 56, no. 7, pp. 941-948, 2007.
238. B. Stecher, R. Robbiani, A. W. Walker et al., "Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota," PLoS Biology, Vol. 5, no. 10, pp. 2177-2189, 2007.
239. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 27, pp. 12204-12209, 2010.
240. D. A. Hill and D. Artis, "Intestinal bacteria and the regulation of immune cell homeostasis," Annual Review of Immunology, Vol. 28, pp. 623-667, 2010.
241. M. M. Heimesaat, S. Bereswill, A. Fischer et al., "Gramnegative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii," Journal of Immunology, Vol. 177, no. 12, pp. 8785-8795, 2006.
242. T. Hand and Y. Belkaid, "Microbial control of regulatory and effector T cell responses in the gut," Current Opinion in Immunology, Vol. 22, no. 1, pp. 63-72, 2010.
243. J. M. Brenchley, D. A. Price, T. W. Schacker et al., "Microbial translocation is a cause of systemic immune activation in chronic HIV infection," Nature Medicine, Vol. 12, no. 12, pp. 1365-1371, 2006.
244. N. G. Sandler and D. C. Douek, "Microbial translocation in HIV infection: causes, consequences and treatment opportunities," Nature Reviews Microbiology, Vol. 10, no. 9, pp. 655-666, 2012.
245. I. Vujkovic-Cvijin, R. M. Dunham, S. Iwai et al., "Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism," Science Translational Medicine, Vol. 5, no. 193, Article ID 193ra91, 2013.
246. U. Hofer, E. Schlaepfer, S. Baenziger et al., "Inadequate clearance of translocated bacterial products in HIV-infected humanized mice," PLoS Pathogens, Vol. 6, no. 4, Article ID e1000867, 2010.
247. J. Henao-Mejia, E. Elinav, C. Jin et al., "Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity," Nature, Vol. 482, no. 7384, pp. 179-185, 2012.
248. K. Schroder and J. Tschopp, "The Inflammasomes," Cell, Vol. 140, no. 6, pp. 821-832, 2010.
249. M. L. Balmer, E. Slack, A. de Gottardi et al., "The liver may act as a frewall mediating mutualism between the host and its gut commensal microbiota," Science Translational Medicine, Vol. 6, no. 237, Article ID 237ra66, 2014.
250. J. Qin, Y. Li, Z. Cai, and et al, "A metagenome-wide association study of gut microbiota in type 2 diabetes," Nature, Vol. 490, no. 7418, pp. 55-60, 2012.
251. D. Gevers, S. Kugathasan, L. A. Denson et al., "The treatment-naive microbiome in new-onset Crohn's disease," Cell Host & Microbe, Vol. 15, pp. 382-392, 2014.
252. E. Papa, M. Docktor, C. Smillie et al., "Non-invasive mapping of the gastrointestinal microbiota identifies children with inflam-matory bowel disease," PLoS ONE, Vol. 7, no. 6, Article ID e39242, 2012.
253. S. E. Winter and A. J. Baumler, "Dysbiosis in the inflamed intestine: chance favors the prepared microbe," Gut Microbes, Vol. 5, no. 1, pp. 71-73, 2014.
254. B. Stecher, R. Denzler, L. Maier et al., "Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae," Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, no. 4, pp. 1269-1274, 2012.
255. + regulatory T cells in the lamina propria," Immunity, Vol. 34, no. 2, pp. 237-246, 2011.
256. C. O'Mahony, P. Scully, D. O'Mahony et al., "Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation," PLoS Pathogens, Vol. 4, no. 8, Article ID e1000112, 2008.
257. I. R. Cohen and L. C. Norins, "Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M," Science, Vol. 152, no. 3726, pp. 1257-1259, 1966.
258. G. P. Manukyan, K. A. Ghazaryan, Z. A. Ktsoyan et al., "Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition," PLoS ONE, Vol. 3, no. 9, Article ID e3172, 2008.
259. H. Scott, T. O. Rognum, T. Midtvedt, and P. Brandtzaeg, "Age-related changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzyme-linked immunosorbent assay," Acta Pathologica Microbiologica et Immunologica Scandinavica C: Immunology, Vol. 93, no. 2, pp. 65-70, 1985.
260. A. Haas, K. Zimmermann, F. Graw et al., "Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection," Gut, Vol. 60, no. 11, pp. 1506-1519, 2011.
261. V. Pascual, R. Dieli-Crimi, N. López-Palacios, A. Bodas, L. M. Medrano, and C. Núñez, "inflammatory bowel disease and celiac disease: overlaps and differences," World Journal of Gastroenterology, Vol. 20, no. 17, pp. 4846-4856, 2014.
262. J. Ezri, P. Marques-Vidal, and A. Nydegger, "Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease," Digestion, Vol. 85, no. 4, pp. 308-319, 2012.
263. D. Comito, A. Cascio, and C. Romano, "Microbiota biodiversity in inflammatory bowel disease," Italian Journal of Pediatrics, Vol. 40, no. 1, article 32, 2014.
264. J. R. Allegretti and M. J. Hamilton, "Restoring the gut micro-biome for the treatment of inflammatory bowel diseases," World Journal of Gastroenterology, Vol. 20, no. 13, pp. 3468-3474, 2014.
265. D. Corridoni, K. O. Arseneau, M. G. Cifone et al., "The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation," Frontiers in Immunology, Vol. 5, article 317, 2014.
266. J. Z. Liu and C. A. Anderson, "Genetic studies of Crohn's disease: past, present and future," Best Practice & Research Clinical Gastroenterology, Vol. 28, no. 3, pp. 373-386, 2014.
267. H. zur Hausen, "The search for infectious causes of human cancers: where and why," Virolog y, Vol. 392, no. 1, pp. 1-10, 2009.
268. I. Lee, "Critical pathogenic steps to high risk gastritis and gastric carcinogenesis," World Journal of Gastroenterology, Vol. 20, pp. 6412-6419, 2014.
269. N. Wu, X. Yang, R. Zhang et al., "Dysbiosis signature of fecal microbiota in colorectal cancer patients," Microbial Ecology, Vol. 66, no. 2, pp. 462-470, 2013.
270. T. Wang, G. Cai, Y. Qiu et al., "Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers," The ISME Journal, Vol. 6, no. 2, pp. 320-329, 2012.
271. N. U. Toprak, A. Yagci, B. M. Gulluoglu et al., "A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer," Clinical Microbiology and Infection, Vol. 12, no. 8, pp. 782-786, 2006.
272. T. P. Prindiville, R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva Jr., "Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease," Emerging Infectious Diseases, Vol. 6, no. 2, pp. 171-174, 2000.
273. C. Basset, J. Holton, A. Bazeos, D. Vaira, and S. Bloom, "Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?" Digestive Diseases and Sciences, Vol. 49, no. 9, pp. 1425-1432, 2004.
274. J. M. Kim, Y. K. Oh, Y. J. Kim, H. B. Oh, and Y. J. Cho, "Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-κB plays a major role in the regulation of IL-8 expression," Clinical and Experimental Immunology, Vol. 123, no. 3, pp. 421-427, 2001.
275. L. Sanfilippo, C. K. F. Li, R. Seth, T. J. Balwin, M. G. Menozzi, and Y. R. Mahida, "Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-β) by human colonic epithelial cells," Clinical and Experimental Immunology, Vol. 119, no. 3, pp. 456-463, 2000.
276. S. Wu, J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears, "Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway," Infection and Immunity, Vol. 72, no. 10, pp. 5832-5839, 2004.
277. S. Wu, P. J. Morin, D. Maouyo, and C. L. Sears, "Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation," Gastroenterology, Vol. 124, no. 2, pp. 392-400, 2003.
278. J. C. Arthur, E. Perez-Chanona, M. Mühlbauer et al., "Intestinal inflammation targets cancer-inducing activity of the micro-biota," Science, Vol. 338, no. 6103, pp. 120-123, 2012.
279. S. Umar, "Citrobacter infection and wnt signaling," Current Colorectal Cancer Reports, Vol. 8, no. 4, pp. 298-306, 2012.
280. H. Zeng, A. Q. Carlson, Y. Guo et al., "Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella," Journal of Immunology, Vol. 171, no. 7, pp. 3668-3674, 2003.
281. Y. C. Ju, D. A. Antonopoulos, A. Kalra et al., "Decreased diversity of the fecal microbiome in recurrent Clostridium dificile-associated diarrhea," Journal of Infectious Diseases, Vol. 197, no. 3, pp. 435-438, 2008.
282. M. A. Bisi-Johnson, C. L. Obi, S. D. Vasaikar, K. A. Baba, and T. Hattori, "Molecular basis of virulence in clinical isolates of Escherichia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South Africa," Gut Pathogens, Vol. 3, no. 1, article 9, 2011.
283. C. D. Garner, D. A. Antonopoulos, B. Wagner et al., "Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection," Infection and Immunity, Vol. 77, no. 7, pp. 2691-2702, 2009.
284. A. Croswell, E. Amir, P. Teggatz, M. Barman, and N.H. Salzman, "Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection," Infection and Immunity, Vol. 77, no. 7, pp. 2741-2753, 2009.
285. G. M. Pupo, D. K. R. Karaolis, R. Lan, and P. R. Reeves, "Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme elec-trophoresis and mdh sequence studies," Infection and Immunity, Vol. 65, no. 7, pp. 2685-2692, 1997.
286. J. Garmendia, G. Frankel, and V. F. Crepin, "Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation," Infection and Immunity, Vol. 73, no. 5, pp. 2573-2585, 2005.
287. S. Fukuda, H. Toh, K. Hase et al., "Bifidobacteria can protect from enteropathogenic infection through production of acetate," Nature, Vol. 469, no. 7331, pp. 543-547, 2011.
288. R. Maltby, M. P. Leatham-Jensen, T. Gibson, P. S. Cohen, and T. Conway, "Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine," PLoS ONE, Vol. 8, no. 1, Article ID e53957, 2013.
289. N. Kamada, Y.-G. Kim, H. P. Sham et al., "Regulated virulence controls the ability of a pathogen to compete with the gut microbiota," Science, Vol. 336, no. 6086, pp. 1325-1329, 2012.
290. + cells that provide innate mucosal immune defense," Immunity, Vol. 29, no. 6, pp. 958-970, 2008.
291. V. Shankar, M. J. Hamilton, A. Khoruts et al., "Species and genus level resolution analysis of gut microbiota in Clostridium dificile patients following fecal microbiota transplantation," Microbiome, Vol. 2, article 13, 2014.
292. C. Seretis, F. Seretis, and K. Goonetilleke, "Appendicectomy and Clostridium dificile infection: is there a link?" Journal of Clinical Medicine Research, Vol. 6, pp. 239-241, 2014.
293. K. E. Burke and J. T. Lamont, "Clostridium dificile infection: a worldwide disease," Gut and Liver, Vol. 8, no. 1, pp. 1-6, 2014.
294. M. Medina, E. Izquierdo, S. Ennahar, and Y. Sanz, "Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications," Clinical & Experimental Immunology, Vol. 150, no. 3, pp. 531-538, 2007.
295. I. Hojsak, N. Snovak, S. Abdović, H. Szajewska, Z. Mišak, and S. Kolaček, "Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial," Clinical Nutrition, Vol. 29, no. 3, pp. 312-316, 2010.
296. N. P. McNulty, T. Yatsunenko, A. Hsiao et al., "The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins," Science Translational Medicine, Vol. 3, no. 106, Article ID 106ra106, 2011.
297. P. Veiga, C. A. Gallini, C. Beal et al., "Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes," Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, no. 42, pp. 18132-18137, 2010.
298. A. T. Vieira, M. M. Teixeira, and F. S. Martins, "The role of probiotics and prebiotics in inducing gut immunity," Frontiers in Immunology, Vol. 4, article 445, 2013.
299. S. C. Corr, Y. Li, C. U. Riedel, P. W. O'Toole, C. Hill, and C. G. M. Gahan, "Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118," Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, no. 18, pp. 7617-7621, 2007.
300. F. S. Martins, G. Dalmasso, R. M. E. Arantes et al., "Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection," PLoS ONE, Vol. 5, no. 1, Article ID e8925, 2010.
301. S. Lebeer, J. Vanderleyden, and S. C. J. de Keersmaecker, "Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens," Nature Reviews Microbiology, Vol. 8, no. 3, pp. 171-184, 2010.
302. R. Mohan, C. Koebnick, J. Schildt, M. Mueller, M. Radke, and M. Blaut, "Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants," Pediatric Research, Vol. 64, no. 4, pp. 418-422, 2008.
303. F. S. Martins, A. T. Vieira, S. D. A. Elian et al., "Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice," Microbes and Infection, Vol. 15, no. 4, pp. 270-279, 2013.
304. P. W. Lin, L. E. S. Myers, L. Ray et al., "Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation," Free Radical Biology and Medicine, Vol. 47, no. 8, pp. 1205-1211, 2009.
305. C. Dai, C.-Q. Zheng, F.-J. Meng, Z. Zhou, L.-X. Sang, and M. Jiang, "VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis," Molecular and Cellular Biochemistry, Vol. 374, no. 1-2, pp. 1-11, 2013.
306. L. M. dos Santos, M. M. Santos, H. P. de Souza Silva, R. M. E. Arantes, J. R. Nicoli, and L. Q. Vieira, "Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection," Medical Microbiology and Immunology, Vol. 200, no. 1, pp. 29-38, 2011.
307. J. Bassaganya-Riera, M. Viladomiu, M. Pedragosa, C. de Simone, and R. Hontecillas, "Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria," PloS ONE, Vol. 7, no. 4, Article ID e34676, 2012.
308. A. Hayashi, T. Sato, N. Kamada et al., "A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice," Cell Host and Microbe, Vol. 13, no. 6, pp. 711-722, 2013.
309. G. R. D'Haens, R. B. Sartor, M. S. Silverberg, J. Petersson, and P. Rutgeerts, "Future directions in inflammatory bowel disease management," Journal of Crohn's and Colitis, Vol. 8, no. 8, pp. 726-734, 2014.
310. G. R. Veerappan, J. Betteridge, and P. E. Young, "Probiotics for the treatment of inflammatory bowel disease," Current Gastroenterology Reports, Vol. 14, no. 4, pp. 324-333, 2012.
311. E. Park, G.-I. Jeon, J.-S. Park, and H.-D. Paik, "A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat," Biological and Pharmaceutical Bulletin, Vol. 30, no. 3, pp. 569-574, 2007.
312. Y. Kim, D. Lee, D. Kim et al., "Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212," Archives of Pharmacal Research, Vol. 31, no. 4, pp. 468-473, 2008.
313. R. Satish Kumar, P. Kanmani, N. Yuvaraj et al., "Lactobacillus plantarum AS1 isolated from South Indian fermented food Kallappam suppress 1, 2-dimethyl hydrazine (DMH)-induced colorectal cancer in male wistar rats," Applied Biochemistry and Biotechnology, Vol. 166, no. 3, pp. 620-631, 2012.
314. V. Pala, S. Sieri, F. Berrino et al., "Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort," International Journal of Cancer, Vol. 129, no. 11, pp. 2712-2719, 2011.
315. N. B. O. Corrêa, F. J. Penna, F. M. L. S. Lima, J. R. Nicoli, and L. A. P. Filho, "Treatment of acute diarrhea with saccharomyces boulardii in infants," Journal of Pediatric Gastroenterology and Nutrition, Vol. 53, no. 5, pp. 497-501, 2011.
316. H. Szajewska, A. Skorka, M. Ruszczynski, and D. Gieruszczak-Białek, "Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials," Alimentary Pharmacology and Therapeutics, Vol. 38, no. 5, pp. 467-476, 2013.
317. N. B. Corrêa, L. A. Péret Filho, F. J. Penna, F. M. L. S. Lima, and J. R. Nicoli, "A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants," Journal of Clinical Gastroenterology, Vol. 39, no. 5, pp. 385-389, 2005.
318. M. K. Salminen, S. Tynkkynen, H. Rautelin et al., "Lactobacillus bacteremia during a rapid increase in probiotic use of Lacto-bacillus rhamnosus GG in Finland," Clinical Infectious Diseases, Vol. 35, no. 10, pp. 1155-1160, 2002.
319. T. Lherm, C. Monet, B. Nougière et al., "Seven cases of fungemia with Saccharomyces boulardii in critically ill patients," Intensive Care Medicine, Vol. 28, no. 6, pp. 797-801, 2002.
320. S. Cesaro, P. Chinello, L. Rossi, and L. Zanesco, "Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii," Supportive Care in Cancer, Vol. 8, no. 6, pp. 504-505, 2000.
321. A. N. Kunz, J. M. Noel, and M. P. Fairchok, "Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome," Journal of Pediatric Gastroenterology and Nutrition, Vol. 38, no. 4, pp. 457-458, 2004.
322. E. Connolly, T. Abrahamsson, and B. Björkstén, "Safety of D(-)-lactic acid producing bacteria in the human infant," Journal of Pediatric Gastroenterology and Nutrition, Vol. 41, no. 4, pp. 489-492, 2005.
323. P. Kochan, A. Chmielarczyk, L. Szymaniak et al., "Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient-is the time right to revise probiotic safety guidelines?" Clinical Microbiology and Infection, Vol. 17, no. 10, pp. 1589-1592, 2011.
324. M. Egervärn, H. Lindmark, J. Olsson, and S. Roos, "Trans-ferability of a tetracycline resistance gene from probiotic Lac-tobacillus reuteri to bacteria in the gastrointestinal tract of humans," Antonie van Leeuwenhoek, Vol. 97, no. 2, pp. 189-200, 2010.